Cargando…
Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives
Amyotrophic lateral sclerosis (ALS) is a clinically heterogeneous disorder characterized by degeneration of upper motor neurons in the brainstem and lower motor neurons in the spinal cord. Multiple mechanisms of motor neuron injury have been implicated, including more than 20 different genetic facto...
Autores principales: | Cieślak, M., Roszek, K., Wujak, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439052/ https://www.ncbi.nlm.nih.gov/pubmed/30430356 http://dx.doi.org/10.1007/s11302-018-9633-4 |
Ejemplares similares
-
Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
por: Raffaele, Stefano, et al.
Publicado: (2021) -
The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications
por: Guo, Wenting, et al.
Publicado: (2020) -
The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment
por: Cieślak, Marek, et al.
Publicado: (2015) -
Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications
por: Liu, Jia, et al.
Publicado: (2017) -
Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach
por: Kumar, Alok, et al.
Publicado: (2013)